Healthpeak Properties (NYSE:DOC) Price Target Lowered to $21.00 at Scotiabank

Healthpeak Properties (NYSE:DOC - Get Free Report) had its price objective cut by stock analysts at Scotiabank from $23.00 to $21.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has a "sector outperform" rating on the real estate investment trust's stock. Scotiabank's target price points to a potential upside of 19.49% from the company's current price.

Other research analysts have also recently issued reports about the company. Wedbush lowered their target price on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Morgan Stanley upgraded Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 target price on the stock in a report on Wednesday, January 15th. Argus restated a "buy" rating and set a $25.00 target price on shares of Healthpeak Properties in a report on Tuesday, April 29th. Robert W. Baird lowered their target price on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a report on Tuesday, April 29th. Finally, StockNews.com cut Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Thursday, May 1st. One research analyst has rated the stock with a sell rating, three have issued a hold rating and nine have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $23.25.

Healthpeak Properties Price Performance

DOC stock traded up $0.11 during trading on Monday, hitting $17.58. The stock had a trading volume of 2,394,933 shares, compared to its average volume of 4,944,249. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. Healthpeak Properties has a twelve month low of $17.21 and a twelve month high of $23.26. The stock has a market capitalization of $12.21 billion, a P/E ratio of 50.19, a PEG ratio of 2.17 and a beta of 1.05. The company's 50-day moving average price is $19.08 and its two-hundred day moving average price is $20.22.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.46. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The company had revenue of $702.89 million for the quarter, compared to analysts' expectations of $690.76 million. During the same period in the previous year, the firm posted $0.45 EPS. Healthpeak Properties's revenue was up 15.9% compared to the same quarter last year. As a group, research analysts predict that Healthpeak Properties will post 1.86 EPS for the current fiscal year.

Insider Activity

In other Healthpeak Properties news, CEO Scott M. Brinker bought 11,337 shares of Healthpeak Properties stock in a transaction dated Monday, April 28th. The stock was acquired at an average cost of $17.68 per share, with a total value of $200,438.16. Following the completion of the acquisition, the chief executive officer now owns 201,863 shares of the company's stock, valued at approximately $3,568,937.84. This represents a 5.95% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director John T. Thomas bought 4,200 shares of Healthpeak Properties stock in a transaction dated Monday, April 28th. The stock was acquired at an average cost of $17.84 per share, with a total value of $74,928.00. Following the completion of the acquisition, the director now directly owns 813,566 shares of the company's stock, valued at approximately $14,514,017.44. The trade was a 0.52% increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 0.23% of the company's stock.

Institutional Investors Weigh In On Healthpeak Properties

A number of institutional investors and hedge funds have recently made changes to their positions in DOC. TCTC Holdings LLC raised its holdings in Healthpeak Properties by 124.3% during the first quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock worth $27,000 after purchasing an additional 751 shares in the last quarter. Mizuho Bank Ltd. purchased a new position in Healthpeak Properties during the fourth quarter worth about $28,000. Harvest Fund Management Co. Ltd purchased a new position in Healthpeak Properties during the fourth quarter worth about $30,000. Future Financial Wealth Managment LLC purchased a new position in Healthpeak Properties during the first quarter worth about $30,000. Finally, S.A. Mason LLC raised its holdings in Healthpeak Properties by 160.9% during the first quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock worth $30,000 after purchasing an additional 925 shares in the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.